Target
D(2) dopamine receptor
Ligand
BDBM50048821
Substrate
n/a
Meas. Tech.
ChEMBL_61415 (CHEMBL675883)
IC50
7.6±n/a nM
Citation
 Norman, MHMinick, DJRigdon, GC Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivatives. J Med Chem 39:149-57 (1996) [PubMed]  Article 
Target
Name:
D(2) dopamine receptor
Synonyms:
DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2_RAT | Dopamine D2 receptor | Dopamine2-like | Drd2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
50931.60
Organism:
Rattus norvegicus (rat)
Description:
P61169
Residue:
444
Sequence:
MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
  
Inhibitor
Name:
BDBM50048821
Synonyms:
2-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-cyclohexyl]-2,3-dihydro-isoindol-1-one | CHEMBL41309
Type:
Small organic molecule
Emp. Form.:
C25H28N4OS
Mol. Mass.:
432.581
SMILES:
O=C1N(Cc2ccccc12)C1CCC(CC1)N1CCN(CC1)c1nsc2ccccc12 |(5.61,-11.3,;4.82,-12.63,;5.59,-14.05,;4.24,-15.07,;2.92,-14.27,;1.45,-14.71,;.31,-13.66,;.68,-12.16,;2.14,-11.71,;3.27,-12.75,;7.09,-14.4,;7.25,-15.93,;9.06,-16.06,;9.97,-16.91,;9.8,-15.39,;8.07,-15.29,;11.46,-17.3,;11.44,-15.77,;12.79,-15,;14.12,-15.77,;14.11,-17.31,;12.79,-18.08,;15.46,-15,;15.63,-13.48,;17.12,-13.15,;17.89,-14.5,;19.39,-14.81,;19.87,-16.27,;18.85,-17.42,;17.33,-17.1,;16.87,-15.63,)|
Structure:
Search PDB for entries with ligand similarity: